Antigenics, Inc. (NASDAQ:AGEN)
CAPS Rating:
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
Growing the love for investing
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Time to buy.... stock has finished consolidating... recent upward change to private placement price, plus recent move in stock price confirms big money wants in... should see a nice run as summer ends and we get closer to EMEA decision